Tuesday, April 9, 2019
3:30 to 4:30 p.m. (EST)
In its first year of implementation, New York’s Medicaid Drug Cap received national attention for its unique approach to the rising cost of prescription drugs. The cap allows the New York Health Commissioner to negotiate a supplemental rebate with manufacturers if spending on a drug exceeds the cap. Entering its second year of implementation, what have state officials learned? How have assessments from the Institute for Clinical and Economic Review (ICER) informed New York’s process? Join NASHP for a state officials-only webinar to hear updates about New York’s Medicaid Drug Cap and learn more about ICER’s approach of bringing a focus on value to the current debate on high-priced prescription drugs. This webinar provides an opportunity for state officials to ask questions and explore more about what ICER is – and isn’t- and about how New York’s experience might inform other state action. This webinar is for state officials only, and will not be recorded.
The moderator is NASHP Executive Director Trish Riley.
- Amir Bassiri, MA, Senior Policy Advisor for Health, Office of Governor Andrew M. Cuomo
- Steven D. Pearson, MD, MSc, Founder and President, Institute for Clinical and Economic Review (ICER)